These results demonstrate that NASP activates the STAT3 pathway and that WP1066, an inhibitor of the STAT3 pathway, enhances the therapeutic effect of radiotherapy on GBM in vitro and in vivo. The gene discussed is STAT3; the disease is glioblastoma.